Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-018643
Filing Date
2025-07-01
Accepted
2025-07-01 14:00:33
Documents
1
Period of Report
2025-06-27

Document Format Files

Seq Description Document Type Size
1 form4-07012025_060730.html 4  
1 form4-07012025_060730.xml 4 3906
  Complete submission text file 0001415889-25-018643.txt   5474
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Dogwood Therapeutics, Inc. (Issuer) CIK: 0001818844 (see all company filings)

EIN.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address
Duncan Gregory Scott (Reporting) CIK: 0001831127 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39811 | Film No.: 251095569